Spironolactone - Heart failure

You are here : Home > Formulary Search > Spironolactone - Heart failure

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green

Formulations :

Oral solution
Tablets

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Associated Icons :

Guidelines BNF SPC

Restrictions / Comments :

Important

Preferred

Spironolactone is the preferred aldosterone antagonist for all stages of heart failure.

Documentation

Guidelines (Local)

Spironolactone monitoring in combination with Renin-angiotensin - Jul 16

PAD Profile

ChemicalSubstance :

Spironolactone

Indication :

Heart failure

Group Name :

Keywords :

potassium sparing diuretics, aldosterone antagonists, hyperkalaemia

Brand Names Include :

Aldactone

Important Information :

Latest Additions Date From :

Latest Additions Date To :

Guidelines :

Heart failure

Supporting Documents :

Other Indications

Below are listed other indications that Spironolactone is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Heart failure.

Committee Recommendations (1)

03 May 17 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

GENERIC Spironolactone has been considered by the PCN and has been assigned a GREEN traffic light status.

NOTE - the branded product, Aldactone, was considered BLACK at the PCN in May 2017.

SAFETY NOTICE: In Feb 2016 the MHRA highlighted the risk of potentially fatal hyperkalaemia when spironolactone is used in combination with a renin-angiotensin drug in heart failure. The MCG approved the content of a guide which clarifies the monitoring requirements for patients on this combination - see guide below